Clinical Trial Update: Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Over 80 Years [Phase 2]

View source ↗

Summary

A Phase 2 trial studying Mini-ChOP plus Ofatumumab for first-line treatment of CD20-positive diffuse large B-cell lymphoma in patients over 80 years old; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Ofatumumab (ofatumumab)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Non Previously Treated CD20+ Diffuse Large B-cell Lymphoma | Phase 2 | Status: COMPLETED